seed
Stage
1
Investors
About
Kylys Aesthetics develops medical devices for aesthetic medicine based on a patented regenerative hyaluronic acid technology from the University of Geneva that stimulates tissue regeneration, offering safer, more natural, and longer-lasting results than conventional dermal fillers.
Explore Kylys Aesthetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.